natgillin/translations-raw huggingface dataset:
Your ability to concentrate or to react will be less during a hypo. Never drive or use machinery if you feel a hypo coming on.
Vaša sposobnost za koncentracijo ali reagiranje se med hipo zmanjša.
POSSIBLE SIDE EFFECTS
Možni neželeni uinki).
EXP/
do/
Subcutaneous or intravenous use Read the package leaflet before use
Pred uporabo natan no preberite priloženo navodilo!
NAME OF THE MEDICINAL PRODUCT Velosulin 100 IU/ml solution for injection or infusion in a vial Insulin human (rDNA)
Velosulin 100 i.e./ml raztopina za injiciranje ali infundiranje v viali humani insulin (rDNA)
Draw the right dose of insulin into the syringe Pull the needle out of the vial
Potegnite v brizgo pravi odmerek insulina.
GENERAL CLASSIFICATION FOR SUPPLY Medicinal product subject to medical prescription
Imetnik dovoljenja za promet z zdravilom in izdelovalec
Marketing Authorisation Holder and Manufacturer Novo Nordisk A/S
Novo Nordisk A/S Novo Nordisk A/S Novo Allé
If severe hypoglycaemia is not treated, it can cause brain damage (temporary or permanent)
Nezdravljena huda hipoglikemija lahko povzro i (prehodno ali trajno) okvaro možganov in e doživite hipo, zaradi katere se onesvestite, ali doživljate veliko hip, se posvetujte z zdravnikom.
Oedema may occur upon initiation of insulin therapy.
Ob asni- edemi Po za etku zdravljenja z insulinom se lahko pojavijo edemi.
Upon regaining consciousness, administration of oral carbohydrate is recommended for the
Ko se bolnik zave, je priporo ljivo, da peroralno dobi ogljikove hidrate za prepre itev ponovitve.
NAME OF THE MEDICINAL PRODUCT Velosulin 100 IU/ml solution for injection or infusion in a vial.
Velosulin 100 i.e./ml raztopina za injiciranje ali infundiranje v viali
Frequencies of adverse drug reactions from clinical trials that are considered related to fast-acting ≥1/1,000 to human insulin (Actrapid) are listed below.
Spodaj so navedene pogostnosti neželenih reakcij nastalih v klini nih preskušanjih, ki so po splošni presoji povezane z zdravilom Velosulin.
- If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet,
- e kateri koli neželeni u inek postane resen ali e opazite katerikoli neželeni u inek, ki ni omenjen v tem navodilu, obvestite svojega zdravnika, diabetološko sestro ali farmacevta.
Patients should be closely monitored throughout this period.
Bolnike je treba ves ta čas skrbno nadzorovati.
EXP Use within 3 months after first opening.
EXP: Uporabite v 3 mesecih po prvem odprtju.
Currently available data are described in section 5.1 but no recommendation on a posology can be made.
Trenutno razpoložljivi podatki so opisani v poglavju 5.1, vendar pa priporočil o odmerjanju ni mogoče podati.
DATE OF FIRST AUTHORISATION/RENEWAL OF THE AUTHORISATION Date of first authorisation: 20 August 2015
Datum prve odobritve: 20. avgust 2015
Consequently, the frequency of these adverse events is qualified as "not known"
Zato je pogostnost teh neželenih učinkov opredeljena kot »neznana«.
There are a further 154 cumulative spontaneous reports of eye movement disorder, of which 22 were serious.
Obstaja še skupaj 154 spontanih poročil o motnjah gibanja oči, od katerih je bilo 22 resnih.
1407 Sofia, Bulgaria Teл.
1407 Sofia, BulgariaTeл.
Use within 3 months after first opening of the bottle.
Uporabite v 3 mesecih po prvem odprtju plastenke.
Str. Livezeni nr. 7A Târgu Mureş 540472 Romania
Str. Livezeni nr. 7A Târgu Mureş 540472 Romunija
indinavir, ritonavir)
npr. indinavir, ritonavir),
Moreover there is also some evidence based on scientific literature that the use of antipsychotics (even second generation antipsychotics like aripiprazole) is associated with an increase in the risk of falls and fractures, especially among the older population.
Poleg tega obstajajo nekateri dokazi, ki temeljijo na znanstveni literaturi, da je uporaba antipsihotikov (celo druga generacija antipsihotikov, kot je aripiprazol) povezana s povečanim tveganjem za pojav padcev in zlomov, zlasti med starejšo populacijo.
If you are an elderly patient suffering from dementia (loss of memory and other mental abilities), you or your carer/relative should tell your doctor if you have ever had a stroke or "mini" stroke.
Če ste starejši bolnik in imate demenco (slabšanje spomina in drugih duševnih sposobnosti), morate vi ali vaš skrbnik/sorodnik zdravniku povedati, če ste kdaj imeli možgansko kap ali "malo" kap.
Less than 1% of unchanged aripiprazole was excreted in the urine and approximately 18% was recovered unchanged in the faeces.
Manj kot 1 % aripiprazola se je nespremenjenega izločilo v urin in približno 18 % ga je bilo mogoče nespremenjenega najti v blatu.
This leaflet was last revised in {MM/YYYY}.
Navodilo je bilo nazadnje revidirano dne <{MM/LLLL}
[Only Carton for bottle:] PC: {number} SN: {number} NN: {number}
[Samo za zunanjo ovojnino plastenke:] PC: {številka}
Try to take Aripiprazole Sandoz at the same time each day.
Prizadevajte si vzeti zdravilo Aripiprazol Sandoz vsak dan ob istem času.
Do not take Aripiprazole Sandoz • if you are allergic to aripiprazole or any of the other ingredients of this medicine (listed in section 6).
Ne jemljite zdravila Aripiprazol Sandoz če ste alergični na aripiprazol ali katero koli sestavino tega zdravila (navedeno v poglavju 6).
During antipsychotic treatment, improvement in the patient's clinical condition may take several days to some weeks.
Med antipsihotičnim zdravljenjem lahko do izboljšanja bolnikovega kliničnega stanja mine od nekaj dni do nekaj tednov.
The requirements for submission of periodic safety update reports for this medicinal product are set out in the list of Union reference dates (EURD list) provided for under Article 107c(7) of Directive 2001/83/EC and any subsequent updates published on the European medicines web-portal.
• Redno posodobljena poročila o varnosti zdravila (PSUR) Zahteve za predložitev redno posodobljenih poročil o varnosti zdravila za to zdravilo so določene v seznamu referenčnih datumov Unije (seznamu EURD), opredeljenem v členu 107c(7) Direktive 2001/83/ES in objavljenem na evropskem spletnem portalu o zdravilih.
Doses higher than 10 mg/day should therefore only be used in exceptional cases and with close clinical monitoring (see sections 4.4, 4.8 and 5.1).
Odmerke, večje od 10 mg/dan je zato treba uporabiti le v izjemnih primerih in ob skrbnem kliničnem nadzoru (glejte poglavja 4.4, 4.8 in 5.1).
If you forget to take Aripiprazole Sandoz If you miss a dose, take the missed dose as soon as you remember but do not take two doses in one day.
Če ste pozabili vzeti zdravilo Aripiprazol Sandoz Če ste pozabili vzeti odmerek, ga vzemite takoj, ko se spomnite, vendar ne vzemite dveh odmerkov na en dan.
Schizophrenia in adolescents aged 15 years and older
Shizofrenija pri mladostnikih, starih 15 let in več
Sandoz GmbH Biochemiestrasse 10 6250 Kundl Austria
Sandoz GmbH Biochemiestrasse 10 6250 Kundl Avstrija
Aripiprazole Sandoz with food, drink and alcohol This medicine can be taken regardless of meals.
Zdravilo Aripiprazol Sandoz skupaj s hrano, pijačo in alkoholom To zdravilo lahko jemljete ne glede na obroke.
The table is based on adverse events reported during clinical trials and/or post-marketing use.
Preglednica temelji na neželenih učinkih, o katerih so poročali med kliničnimi preskušanji in/ali med uporabo v obdobju trženja.
Blood pressure-lowering medicines: Aripiprazole Sandoz may increase the effect of medicines used to lower the blood pressure.
Zdravila za zniževanje krvnega tlaka: zdravilo Aripiprazol Sandoz lahko okrepi učinek zdravil, ki se uporabljajo za zniževanje krvnega tlaka.
Healthcare professionals are asked to report any suspected adverse reactions via the national reporting system listed in Appendix V.
Od zdravstvenih delavcev se zahteva, da poročajo o katerem koli domnevnem neželenem učinku zdravila na: nacionalni center za poročanje, ki je naveden v Prilogi V.
Even if you feel better, do not alter or discontinue the daily dose of Aripiprazole Sandoz without first consulting your doctor.
Tudi če se počutite bolje, ne spreminjajte dnevnega odmerka in ne nehajte jemati zdravila Aripiprazol Sandoz, ne da bi se prej posvetovali z zdravnikom.
Risk factors that may predispose patients to severe complications include obesity and family history of diabetes.
Med dejavniki tveganja, ki lahko povečajo bolnikovo nagnjenost k hudim zapletom, sta debelost in družinska anamneza sladkorne bolezni.
At therapeutic concentrations, aripiprazole and dehydroaripiprazole are greater than 99% bound to serum proteins, binding primarily to albumin.
V terapevtskih koncentracijah je več kot 99 % aripiprazola in dehidroaripiprazola vezanega na beljakovine v serumu, predvsem na albumin.
Based on results of a full range of standard genotoxicity tests, aripiprazole was considered non-genotoxic.
Na podlagi celotnega spektra standardnih preskusov genotoksičnosti je bilo ocenjeno, da aripiprazol ni genotoksičen.
LIST OF EXCIPIENTS Also contains: lactose monohydrate.
SEZNAM POMOŽNIH SNOVI Vsebuje tudi: laktoza monohidrat.
Urinary incontinence Urinary retention
Bolezni sečil urinska inkontinenca retenca urina
The point estimate of the hazard ratio (HR) was 0.461 (95% confidence interval, 0.242-0.879) in the full population.
Ocenjena vrednost razmerja ogroženosti (RO) je bila 0,461 (95% interval zaupanja, 0,242-0,879) pri celotni poulaciji.
If you have the impression that the effect of Aripiprazole Sandozis too strong or too weak, talk to your doctor or pharmacist.
Če menite, da je učinek zdravila Aripiprazol Sandoz premočan ali prešibak, se posvetujte z zdravnikom ali farmacevtom.
Prolactin levels were evaluated in all trials of all doses of aripiprazole (n=28,242).
V vseh preizkušanjih z vsemi odmerki aripiprazola so ocenili ravni prolaktina (n = 28.242).
However, the estimation of the HR for the younger (13-14 years) group was not precise, reflecting the smaller number of subjects in that group (aripiprazole, n = 29; placebo, n = 12), and the confidence interval for this estimation (ranging from 0.151 to 1.628) did not allow conclusions to be drawn on the presence of a treatment effect.
Vendar pa ocena RO pri skupini mlajših mladostnikov (13-14 let) ni bila točna zaradi manjšega števila udeležencev v tej skupini (aripiprazol, n = 29; placebo, n = 12), interval zaupanja za to oceno (ki je od 0,151 do 1,628) pa ne omogoča zaključkov o prisotnosti učinka zdravljenja.
Aluminium//Aluminium blister.
Pretisni omot aluminij/aluminij.
Caution should be taken when treating patients at higher risk, and a lower starting dose should be considered (e.g elderly or debilitated patients) (see section 4.2).
Pri zdravljenju bolnikov z večjim tveganjem je potrebna previdnost, zato je treba razmisliti o nižjem začetnem odmerku (npr. pri starejših ali oslabljenih bolnikih; glejte poglavje 4.2).
If you take more Aripiprazole Sandoz than you should If you realise you have taken more Aripiprazole Sandoz than your doctor has recommended (or if someone else has taken some of your Aripiprazole Sandoz), contact your doctor right away.
Če ste vzeli večji odmerek zdravila Aripiprazol Sandoz, kot bi smeli Če ugotovite, da ste vzeli več zdravila Aripiprazol Sandoz, kot vam je priporočil zdravnik (ali če je vaše zdravilo Aripiprazol Sandoz vzel kdo drug), se takoj posvetujte s svojim zdravnikom.
Aripiprazole Sandoz is effective in a dose range of 10 to 30 mg/day.
Zdravilo Aripiprazol Sandoz je učinkovito v razponu odmerkov od 10 do 30 mg/dan.
The European Medicines Agency has deferred the obligation to submit the results of studies with the reference medicinal product containing aripiprazole in one or more subsets of the paediatric population in the treatment of schizophrenia and in the treatment of bipolar affective disorder (see section 4.2 for information on paediatric use).
Evropska agencija za zdravila je začasno odložila zahtevo za predložitev rezultatov študij z zdravilom Aripiprazol Sandoz za eno ali več podskupin pediatrične populacije pri zdravljenju shizofrenije in bipolarne afektivne motnje (za podatke o uporabi pri pediatrični populaciji glejte poglavje 4.2).
stroke or "mini" stroke, abnormal blood pressure
"malo" kap, nenormalen krvni tlak,
HDPE bottle containing a silica gel desiccant and a polyester coil packed in cartons containing 100 tablets.
Plastenka HDPE, ki vsebuje silikagelno sušilno sredstvo in poliestrski navoj, pakirana v škatlo, ki vsebuje 100 tablet.
In subgroup analyses the point estimate of the HR was 0.495 for subjects 13 to 14 years of age compared to 0.454 for subjects 15 to 17 years of age.
Pri analizi podskupin je bila ocenjena vrednost RO pri udeležencih, starih od 13 do 14 let, 0,495 v primerjavi z udeleženci, starimi od 15 do 17 let, pri katerih je razmerje bilo 0,454.
Aripiprazole Sandoz contains the active substance aripiprazole and belong to a group of medicines called antipsychotics.
Zdravilo Aripiprazol Sandoz vsebuje učinkovino aripiprazol in spada v skupino zdravil, imenovanih antipsihotiki.
In adults it also prevents this condition from returning in patients who have responded to the treatment with Aripiprazole Sandoz.
Zdravilo tudi preprečuje ponovitve bolezni pri odraslih bolnikih, ki so se odzvali na zdravljenje z zdravilom Aripiprazol Sandoz.
Following any confirmed or suspected overdose with aripiprazole, close medical supervision and monitoring should continue until the patient recovers.
Po vsakem potrjenem prevelikem odmerjanju ali sumu na preveliko odmerjanje aripiprazola je potreben skrben zdravniški nadzor in spremljanje, dokler si bolnik ne opomore.
Orodispersible tablets or oral solution may be used as an alternative to Aripiprazole Sandoz tablets for patients who have difficulty swallowing Aripiprazole Sandoz tablets (see section 5.2).
Orodisperzibilne tablete ali peroralna raztopina se lahko uporabijo kot alternativa tabletam Aripiprazol Sandoz pri bolnikih, ki tablete Aripiprazol Sandoz težko pogoltnejo (glejte poglavje 5.2)
Aripiprazol may cause somnolence, postural hypotension, motor and sensory instability, which may lead to falls.
Aripiprazol lahko povzroči somnolenco, posturalno hipotenzijo, motorično in senzorično nestabilnost, ki lahko privedejo do padcev.
It is important that you carry on taking your Aripiprazole Sandoz for as long as your doctor has told you to.
Pomembno je, da zdravljenje z zdravilom Aripiprazol Sandoz nadaljujete tako dolgo, kot vam je svetoval zdravnik.
• blood clots, or family history of blood clots, as antipsychotics have been associated with formation of blood clots
• imate krvne strdke ali težave s krvnimi strdki v družini, antipsihotike namreč povezujejo z nastajanjem krvnih strdkov,
Treatment should be initiated at 2 mg (using an appropriate aripiprazole containing medicinal product) for 2 days, titrated to 5 mg for 2 additional days to reach the recommended daily dose of 10 mg.
Zdravljenje je treba uvesti v odmerku 2 mg (z uporabo ustreznega zdravila, ki vsebuje aripiprazol), ki ga bolnik jemlje 2 dni, nato pa se odmerek poveča do odmerka 5 mg, ki ga bolnik jemlje še dodatna 2 dni.
In three placebo-controlled trials (n=938; mean age: 82.4 years; range: 56-99 years) of aripiprazole in elderly patients with psychosis associated with Alzheimer's disease, patients treated with aripiprazole were at increased risk of death compared to placebo.
V treh s placebom nadzorovanih preskušanjih (n = 938, povprečna starost: 82,4 leta, razpon: 56-99 let) aripiprazola pri starejših bolnikih s psihozo, povezano z Alzheimerjevo boleznijo, je bilo tveganje smrti večje pri bolnikih, ki so dobivali aripiprazol, kot pri tistih, ki so dobivali placebo.
Therefore, Aripiprazole Sandoz is not recommended for use in patients below 13 years of age (see sections 4.8 and 5.1).
Uporabe zdravila Aripiprazol Sandoz se zato pri bolnikih, mlajših od 13 let, ne priporoča (glejte poglavji 4.8 in 5.1).
In contrast the 95% confidence interval for the HR in the older subgroup (aripiprazole, n = 69; placebo, n = 36) was 0.242 to 0.879 and hence a treatment effect could be concluded in the older patients.
V nasprotju s tem je bil 95% interval zapanja za RO pri starejši podskupini (aripiprazol, n = 69; placebo, n = 36) od 0,242 do 0,879, tako da je pri starejših bolnikih mogoče sprejeti zaključek o učinkovitosti zdravljenja.
To allow the start of the treatment at a low dose you can use an alternative formulation (oral solution - liquid) more suitable than Aripiprazole Sandoz tablets.
Zdravnik lahko predpiše to zdravilo v majhnem začetnem odmerku v drugi obliki (peroralna raztopina - tekočina), ki je bolj primerna kot Aripiprazol Sandoz.
Taking Aripiprazole Sandoz with some medicines may mean the doctor will need to change your dose of Aripiprazole Sandoz or the other medicines.
Če jemljete zdravilo Aripiprazol Sandoz z nekaterimi drugimi zdravili, bo morda zdravnik moral spremeniti vaš odmerek zdravila Aripiprazol Sandoz ali drugih zdravil.
Patients treated with any antipsychotic, including aripiprazole, should be observed for signs and symptoms of hyperglycaemia (such as polydipsia, polyuria, polyphagia and weakness) and patients with diabetes mellitus or with risk factors for diabetes mellitus should be monitored regularly for worsening of glucose control (see section 4.8).
Bolnike, ki dobivajo kateri koli antipsihotik, vključno z aripiprazolom, je treba opazovati glede znakov in simptomov hiperglikemije (npr. polidipsije, poliurije, polifagije in šibkosti); bolnike s sladkorno boleznijoali dejavniki tveganja zanjo pa je treba redno nadzirati, da bi odkrili poslabšanje urejenosti glukoze (glejte poglavje 4.8).
United Kingdom Sandoz Limited Frimley Business Park Camberley, GU16 7SR, UK Tel: + 44 1276 698020 uk.regaffairs@sandoz.com
Frimley Business Park Camberley, GU16 7SR, UK Tel: + 44 1276 698020 uk.regaffairs@sandoz.com
The total body clearance of aripiprazole is 0.7 ml/min/kg, which is primarily hepatic.
Celotni telesni očistek aripiprazola je 0,7 ml/min/kg in je v prvi vrsti jetrni.
Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines, including medicines obtained without a prescription.
Druga zdravila in zdravilo Aripiprazol Sandoz Obvestite zdravnika ali farmacevta, če jemljete, ste pred kratkim jemali ali pa boste morda začeli jemati katero koli drugo zdravilo, vključno z zdravili, ki ste jih dobili brez recepta.
• certain medicines to treat HIV infection (such as efavirenz, nevirapine, an protease inhibitors e.g.
• določena zdravila za zdravljenje okužbe s HIV (kot so efavirenz, nevirapin, zaviralci proteaz,
What Aripiprazole Sandoz tablets are and what they are used for What you need to know before you take Aripiprazole Sandoz tablets How to take Aripiprazole Sandoz tablets Possible side effects
Kaj je zdravilo Aripiprazol Sandoz in za kaj ga uporabljamo Kaj morate vedeti, preden boste vzeli zdravilo Aripiprazol Sandoz Kako jemati zdravilo Aripiprazol Sandoz Možni neželeni učinki
There have been reports of agitation, hypertonia, hypotonia, tremor, somnolence, respiratory distress, or feeding disorder.
Poročali so o agitaciji, hipertoniji, hipotoniji, tremorju, somnolenci, respiratorni stiski in motnjah pri hranjenju.
obsessive compulsive disorder (OCD) and social phobia as well as migraine and pain
generalizirano anksiozno motnjo, obsesivno-kompulzivno motnjo (OCD) in socialno fobijo, kot tudi za migrene in bolečine,
Packsizes:
Velikosti pakiranj:
87 cases had medical history of confounding risk factors such as balance disorders, loss of consciousness, syncope, somnolence, extrapyramidal disorder, femoral fracture, alcohol abuse, bundle branch block, osteoporosis, knee arthroplasty, spinal fusion surgery, road traffic accident, fall, transient ischemic attack, cerebrovascular accident, head injury and dementia with Lewy bodies and concomitant therapy with risperidone, quetiapine fumarate, clonazepam, Latuda, valium was a confounding factor in 172 cases.
87 primerov je imelo anamnezo motečih dejavnikov tveganja, kot so motnje ravnovesja, izguba zavesti, sinkopa, somnolenca, ekstrapiramidna motnja, zlom stegnenice, zloraba alkohola, kračni blok, osteoporoza, artroplastika kolena, operacija hrbtenične fuzije, prometna nesreča, padec, prehodni ishemični napad, srčno-žilni dogodek, poškodba glave in demenca z Lewyjevimi telesci, sočasno zdravljenje z risperidonom, kvetiapin fumaratom, klonazepamom, Latudo, valiumom pa je moteče dejavnike izzvalo v 172 primerih.
It has been proposed that aripiprazole's efficacy in schizophrenia and Bipolar I Disorder is mediated through a combination of partial agonism at dopamine D2 and serotonin 5-HT1a receptors and antagonism of serotonin 5-HT2a receptors.
Učinkovitost aripiprazola pri shizofreniji in bipolarni motnji I je domnevno posledica kombinacije delnega agonizma na dopaminskih receptorjih D2 in serotoninskih receptorjih 5-HT1a ter antagonizma na serotoninskih receptorjih 5-HT2a.
Recurrence prevention of manic episodes in Bipolar I Disorder: for preventing recurrence of manic episodes in patients who have been receiving aripiprazole as monotherapy or combination therapy, continue therapy at the same dose.
Preprečevanje ponovitev maničnih epizod pri bipolarni motnji I: za preprečevanje ponovitev maničnih epizod pri bolnikih, ki so se zdravili z aripiprazolom samostojno ali v sklopu kombiniranega zdravljenja, se zdravljenje nadaljuje z istim odmerkom.
Aripiprazole exhibited high binding affinity in vitro for dopamine D2 and D3, serotonin 5-HT1a and 5-HT2a receptors and moderate affinity for dopamine D4, serotonin 5-HT2c and 5-HT7, alpha-1 adrenergic and histamine H1 receptors.
In vitro je imel aripiprazol veliko vezavno afiniteto za dopaminske receptorje D2 in D3 in za serotoninske receptorje 5-HT1a in 5-HT2a ter zmerno afiniteto za dopaminske receptorje D4, serotoninske receptorje 5-HT2c in 5-HT7, adrenergične receptorje alfa-1 in histaminske receptorje H1.
On the basis of the scientific conclusions for aripiprazole the CHMP is of the opinion that the benefit-risk balance of the medicinal product(s) containing aripiprazole is unchanged subject to the proposed changes to the product information.
Podlaga za spremembe pogojev dovoljenja (dovoljenj) za promet z zdravilom Na podlagi znanstvenih zaključkov za zdravilo aripiprazol odbor CHMP meni, da je razmerje med koristjo in tveganjem zdravil(-a), ki vsebuje(-jo) učinkovino aripiprazol, nespremenjeno ob upoštevanju predlaganih sprememb v informacijah o zdravilu.
Quinidine and other CYP2D6 inhibitors
Kinidin in drugi zaviralci CYP2D6
Irritability associated with autistic disorder: the safety and efficacy of Aripiprazole Sandoz in children and adolescents aged below 18 years have not yet been established.
Razdražljivost, povezana z avtistično motnjo: varnost in učinkovitost zdravila Aripiprazol Sandoz pri otrocih in mladostnikih, mlajših od 18 let, še nista bili dokazani.
The 5 mg, 10 mg, 15 mg and 30 mg tablets are supplied in the following presentations: Aluminium//Aluminium blisters packed in cartons containing 10, 14, 16, 28, 30, 35, 56 or 70 tablets.
Tablete z jakostjo 5 mg, 10 mg, 15 mg in 30 mg so na voljo v naslednjih pakiranjih: Pretisni omot aluminij/aluminij v škatlah, ki vsebujejo po 10, 14, 16, 28, 30, 35, 56 ali 70 tablet.
If you are taking Aripiprazole Sandoz, your doctor will discuss with you whether you should breast-feed considering the benefit to you of your therapy and the benefit to your baby of breast-feeding.
Če prejemate zdravilo Aripiprazol Sandoz, vam bo zdravnik pomagal pri odločitvi glede dojenja z upoštevanjem prednosti dojenja za otroka in prednosti zdravljenja za vas.
The safety and efficacy of Aripiprazole Sandoz in the treatment of schizophrenia or manic episodes in Bipolar I Disorder in patients aged 65 years and older has not been established.
Varnost in učinkovitost zdravila Aripiprazol Sandoz nista bili ugotovljeni pri zdravljenju shizofrenije ali maničnih epizod pri bipolarni motnji I pri bolnikih, starih 65 let in starejših.
Carbamazepine and other CYP3A4 inducers
Karbamazepin in drugi induktorji CYP3A4